The store will not work correctly when cookies are disabled.
4-((9H-purin-6-ylthio)methyl)benzonitrile
ID: ALA4744159
PubChem CID: 386903
Max Phase: Preclinical
Molecular Formula: C13H9N5S
Molecular Weight: 267.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1ccc(CSc2ncnc3[nH]cnc23)cc1
Standard InChI: InChI=1S/C13H9N5S/c14-5-9-1-3-10(4-2-9)6-19-13-11-12(16-7-15-11)17-8-18-13/h1-4,7-8H,6H2,(H,15,16,17,18)
Standard InChI Key: OBWUGPIEJGQXCJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
36.1737 -12.0432 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.1726 -12.8628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8806 -13.2717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8789 -11.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5875 -12.0396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5923 -12.8582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3723 -13.1067 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8497 -12.4415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3645 -11.7822 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8764 -10.8172 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
36.1675 -10.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4610 -10.8214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7558 -10.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0498 -10.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0518 -11.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7657 -12.0485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4688 -11.6361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3491 -12.0549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6432 -12.4665 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 3 0
15 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 267.32 | Molecular Weight (Monoisotopic): 267.0579 | AlogP: 2.52 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.25 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.91 | CX Basic pKa: 3.54 | CX LogP: 2.40 | CX LogD: 2.40 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.58 | Np Likeness Score: -1.69 |
References
1. Rojas-Prats E,Martinez-Gonzalez L,Gonzalo-Consuegra C,Liachko NF,Perez C,Ramírez D,Kraemer BC,Martin-Requero Á,Perez DI,Gil C,de Lago E,Martinez A. (2021) Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis., 210 [PMID:33139113] [10.1016/j.ejmech.2020.112968] |